Aflac Incorporated (NYSE:AFL) Shares Acquired by Commonwealth Equity Services LLC

Key Points

• Commonwealth Equity Services LLC increased its stake in Aflac by 12.4%, owning approximately 356,558 shares valued at $39.6 million.
• Wall Street analysts have given Aflac a consensus rating of "Hold" with a target price averaging $108.15 per share.
• Recent insider sales included Director Joseph L. Moskowitz selling 1,000 shares and a significant sale of 37,000 shares by Director Masatoshi Koide, indicating changes in ownership among insiders.

Commonwealth Equity Services LLC boosted its position in Aflac Incorporated (NYSE:AFL - Free Report) by 12.4% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 356,558 shares of the financial services provider's stock after purchasing an additional 39,259 shares during the period. Commonwealth Equity Services LLC owned approximately 0.07% of Aflac worth $39,646,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Golden State Wealth Management LLC boosted its position in Aflac by 121.9% during the first quarter. Golden State Wealth Management LLC now owns 304 shares of the financial services provider's stock valued at $34,000 after purchasing an additional 167 shares during the last quarter. Garde Capital Inc. acquired a new stake in Aflac during the first quarter valued at approximately $36,000. Meeder Asset Management Inc. boosted its holdings in shares of Aflac by 90.8% in the 1st quarter. Meeder Asset Management Inc. now owns 330 shares of the financial services provider's stock worth $37,000 after acquiring an additional 157 shares in the last quarter. Capital A Wealth Management LLC acquired a new position in Aflac during the 4th quarter worth $38,000. Finally, NBC Securities Inc. acquired a new position in Aflac during the 1st quarter worth $44,000. Institutional investors own 67.44% of the company's stock.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on the company. Morgan Stanley increased their target price on Aflac from $100.00 to $105.00 and gave the stock an "equal weight" rating in a report on Monday, May 19th. Barclays set a $98.00 price objective on shares of Aflac and gave the stock an "underweight" rating in a research report on Monday, July 7th. JPMorgan Chase & Co. lifted their price target on shares of Aflac from $96.00 to $100.00 and gave the company a "neutral" rating in a research report on Tuesday, July 8th. Wells Fargo & Company boosted their target price on shares of Aflac from $103.00 to $105.00 and gave the stock an "equal weight" rating in a research note on Thursday, July 10th. Finally, Raymond James Financial cut their price target on shares of Aflac from $115.00 to $110.00 and set an "outperform" rating on the stock in a report on Thursday, May 29th. Three analysts have rated the stock with a sell rating, eight have issued a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat, Aflac has a consensus rating of "Hold" and a consensus target price of $108.15.

Insider Transactions at Aflac

In other Aflac news, Director Joseph L. Moskowitz sold 1,000 shares of the stock in a transaction that occurred on Thursday, May 8th. The shares were sold at an average price of $106.79, for a total value of $106,790.00. Following the transaction, the director directly owned 26,096 shares in the company, valued at $2,786,791.84. This represents a 3.69% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Masatoshi Koide sold 37,000 shares of the stock in a transaction on Tuesday, May 20th. The stock was sold at an average price of $105.59, for a total value of $3,906,830.00. Following the sale, the director directly owned 70,992 shares of the company's stock, valued at approximately $7,496,045.28. This represents a 34.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 40,750 shares of company stock valued at $4,304,295 over the last 90 days. 0.80% of the stock is currently owned by corporate insiders.

Aflac Stock Performance

Shares of NYSE AFL opened at $98.60 on Tuesday. The company has a current ratio of 0.09, a quick ratio of 0.09 and a debt-to-equity ratio of 0.29. Aflac Incorporated has a 12 month low of $95.97 and a 12 month high of $115.50. The company has a 50 day simple moving average of $102.50 and a two-hundred day simple moving average of $105.00. The stock has a market cap of $53.31 billion, a price-to-earnings ratio of 15.41, a PEG ratio of 3.03 and a beta of 0.83.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.